Venus Remedies
-
Venus Remedies secures regulatory approvals for three key oncology drugs in Ukraine
Ukrainian has given marketing approvals for paclitaxel, oxaliplatin and irinotecan Venus Remedies has further expanded the reach of its oncology…
Read More » -
Venus Remedies bags UNICEF GMP approval
Venus Remedies’ manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF Venus…
Read More » -
Venus Remedies bags first incentive of Rs7.50 Cr under PLI scheme
The disbursement will bolster the company’s manufacturing capabilities and foster product diversification, including complex generics Venus Remedies has been awarded…
Read More » -
Venus Remedies gets coveted GMP certification from Libya
The GMP certification for the company’s production facilities has added to its portfolio of international approvals from 25 regulators Venus…
Read More » -
Venus Remedies secures marketing approval from Israel, Colombia for two oncology drugs
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia Venus Remedies, a global leader in…
Read More » -
Venus Remedies bags marketing authorisation for enoxaparin from Azerbaijan
Azerbaijan’s pharmaceutical market is import-dominated, with India accounting for 4-5 per cent of the total pharmaceutical imports Venus Remedies, a…
Read More » -
Venus Remedies bags marketing approvals from Philippines, Saudi Arabia for three drugs
While Saudi Arabia is the largest pharmaceutical market in GCC region, Philippines happens to be the second largest market in…
Read More » -
Venus Remedies secures GoI’s coveted ‘Three Star Export House’ certificate
It is a validation of the company’s commitment to providing high-quality pharmaceutical formulations globally Venus Remedies, a noted name in…
Read More » -
Venus Remedies bags REO Certification from CII for second consecutive year
The company stands at the forefront of responsible and sustainable export practices Venus Remedies has received the highly coveted Responsible…
Read More »